Summary
Each year, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation. This conference will allow attendees to meet and network with the key influencers shaping the law, policy and proceedings of paragraph IV litigation.